FibroBiologics, Inc. (FBLG)
NASDAQ: FBLG · IEX Real-Time Price · USD
10.11
-1.57 (-13.44%)
At close: Apr 26, 2024, 4:00 PM
9.70
-0.41 (-4.06%)
After-hours: Apr 26, 2024, 5:52 PM EDT
FibroBiologics Market Cap
FibroBiologics has a market cap or net worth of $330.79 million as of April 26, 2024.
Market Cap
330.79M
Enterprise Value
323.52M
1-Year Change
n/a
Ranking
Category
Stock Price
$10.11
Market Cap Chart
Since January 31, 2024, FibroBiologics's market cap has decreased from $821.50M to $330.79M, a decrease of -59.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 26, 2024 | 329.90M | -13.46% |
| Apr 25, 2024 | 381.20M | 1.41% |
| Apr 24, 2024 | 375.90M | 3.78% |
| Apr 23, 2024 | 362.20M | 2.66% |
| Apr 22, 2024 | 352.80M | 6.52% |
| Apr 19, 2024 | 331.20M | -7.82% |
| Apr 18, 2024 | 359.30M | 16.02% |
| Apr 17, 2024 | 309.70M | -13.66% |
| Apr 16, 2024 | 358.70M | 3.79% |
| Apr 15, 2024 | 345.60M | -0.95% |
| Apr 12, 2024 | 348.90M | -5.55% |
| Apr 11, 2024 | 369.40M | -2.17% |
| Apr 10, 2024 | 377.60M | 5.77% |
| Apr 9, 2024 | 357.00M | -1.19% |
| Apr 8, 2024 | 361.30M | 0.47% |
| Apr 5, 2024 | 359.60M | -3.33% |
| Apr 4, 2024 | 372.00M | 1.86% |
| Apr 3, 2024 | 365.20M | 3.60% |
| Apr 2, 2024 | 352.50M | -5.34% |
| Apr 1, 2024 | 372.40M | 5.56% |
| Mar 28, 2024 | 352.80M | -8.01% |
| Mar 27, 2024 | 383.50M | 7.51% |
| Mar 26, 2024 | 356.70M | -8.91% |
| Mar 25, 2024 | 391.60M | 0.08% |
| Mar 22, 2024 | 391.30M | -0.91% |
View and export this data all the way back to 2024.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Anika Therapeutics | 379.20M |
| iTeos Therapeutics | 378.86M |
| Pulse Biosciences | 378.85M |
| Cibus | 377.92M |
| Adaptive Biotechnologies | 377.24M |
| Corbus Pharmaceuticals Holdings | 372.92M |
| Revance Therapeutics | 372.05M |
| Surmodics | 371.13M |